시장보고서
상품코드
1986533

프로바이오틱스 시장 보고서 : 성분, 유통 채널, 용도, 형태, 지역별(2026-2034년)

Probiotics Market Report by Ingredient, Distribution Channel, Application, Form, and Region 2026-2034

발행일: | 리서치사: 구분자 IMARC | 페이지 정보: 영문 136 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 프로바이오틱스 시장 규모는 2025년에 719억 달러에 달했습니다. 향후 IMARC Group은 2026년부터 2034년까지 CAGR 6.05%를 기록하며 2034년까지 1,240억 달러에 달할 것으로 예측하고 있습니다. 소화기 질환의 증가, 기능성 식품의 소비 확대, 의약품 개발의 진전이 시장 성장에 영향을 미치고 있습니다.

프로바이오틱스 시장 동향:

기능성 식품에 대한 수요 증가

IMARC Group의 보고서에 따르면, 세계 기능성 식품 시장 규모는 2023년 2,211억 달러로 2032년까지 3,689억 달러에 달할 것으로 예상됩니다. 프로바이오틱스 시장의 주요 촉진요인 중 하나는 기능성 식품에 대한 수요 증가입니다. 소비자들은 영양뿐만 아니라 건강상의 이점을 제공하는 음료와 식품에 대한 관심이 높아지고 있습니다. 프로바이오틱스를 포함한 기능성 식품은 신체 기능을 지원하고 질병을 예방하는 중요한 원천으로 여겨지고 있습니다. 둘째, 건강에 대한 인식이 높아지고 장내 환경의 중요성에 대한 개인의 인식이 이러한 수요를 견인하고 있습니다. 장내 세균총이 전신 건강에 미치는 역할에 대한 이해도가 높아짐에 따라 소화기 건강에 좋은 제품을 구매하고자 하는 욕구가 증가하고 있습니다. 프로바이오틱스는 장내 세균총의 균형을 맞춰 장 건강을 개선하는 천연 유래 제품으로 건강에 관심이 많은 소비자들 사이에서 인기를 끌고 있습니다.

의약품 개발 확대

프로바이오틱스의 작용 기전 및 치료 가능성을 규명하기 위한 연구가 진행됨에 따라, 그 효능을 입증하기 위한 양질의 임상시험 실시에 대한 요구가 높아지고 있습니다. 신약 개발을 위해서는 특정 건강 상태를 치료하는 데 있어 임상적으로 검증된 프로바이오틱스 균주의 안전성과 효능을 입증하는 무작위 대조군 시험이 필수적입니다. 이러한 임상 연구는 프로바이오틱스를 치료제로 사용하는 것을 뒷받침하는 과학적 근거를 만들어내어 소비자의 신뢰를 높이고 프로바이오틱스 시장의 성장을 촉진합니다. 또한, 주요 기업들은 새로운 프로바이오틱스 균주, 제형 및 치료용도에 대한 특허 보호 획득에 집중하면서 프로바이오틱스 의약품 개발에 투자하고 있습니다. 또한, 규제 당국은 제제의 안전성과 안정성을 중시하고 있습니다. 또한, 전 세계적으로 의약품 개발 및 항생제 제조에도 투자하고 있습니다. 예를 들어, 미국 보건복지부는 2022년까지 4,000만 달러를 투자하여 의약품 유효성분(API) 및 항생제 바이오 제조에 대한 역할을 확대했습니다.

호황을 누리고 있는 동물 사료 산업

IMARC Group의 보고서에 따르면, 세계 동물 사료 시장은 2032년까지 6,747억 달러에 달할 것으로 예상됩니다. 가축이나 가금류뿐만 아니라 반려동물에서도 동물의 장 건강의 중요성에 대한 인식이 높아지고 있습니다. 인간과 마찬가지로 장내 미생물총은 소화, 영양소 흡수, 면역 반응, 전반적인 건강 상태 등에 영향을 미쳐 동물의 건강에 필수적인 역할을 합니다. 그 결과, 축산농가와 반려동물 보호자들은 장내 환경을 건강하게 유지하고 동물의 전반적인 성능을 향상시키기 위해 사료에 프로바이오틱스를 점점 더 많이 첨가하고 있습니다. 프로바이오틱스는 사료 효율을 높이고 영양소 이용을 촉진하여 위장 장애를 줄이는 것 외에도 지속가능한 개발 접근법과도 관련이 있습니다. 또한, 프로바이오틱스는 축산 생태계의 생산성과 지속가능성을 높이는데도 활용될 수 있습니다.

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 프로바이오틱스 시장

제6장 시장 내역 : 원재료별

제7장 시장 내역 : 유통 채널별

제8장 시장 내역 : 용도별

제9장 시장 내역 : 형태별

제10장 시장 내역 : 지역별

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 가격 분석

제15장 경쟁 구도

KSM

The global probiotics market size reached USD 71.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 124.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.05% during 2026-2034. Rising digestive issues, the growing consumption of functional food and beverages, and expansion of drug development is impacting the growth of the market.

PROBIOTICS MARKET ANALYSIS:

  • Major Market Drivers: The rising number of digestive disorders is impelling the growth of the market. Additionally, the increasing awareness among individuals about health and wellness is bolstering the market growth.
  • Key Market Trends: The growing aging population is driving the demand for probiotics to improve gut health and immune function, thereby offering a favorable market outlook. In addition, an increase in consumption of functional food and beverages is stimulating the market growth.
  • Geographical Trends: Asia Pacific holds the largest segment because of the growing prevalence of digestive issues, along with the rising aging population.
  • Competitive Landscape: Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd., among many others.
  • Challenges and Opportunities: While the market faces challenges like intense competition and market saturation, which impacts probiotics market revenue and supply-demand imbalances, it also encounters opportunities in the development of production technologies that allows key players to produce probiotics more efficiently and substantially.

PROBIOTICS MARKET TRENDS:

Growing Demand for Functional Food

According to the IMARC Group's report the global functional food market size reached US$ 221.1 Billion in 2023 and expected to reach US$ 368.9 Billion by 2032. One of the significant drivers of the probiotics market is the growing demand for functional foods. Consumers are becoming more interested in food and beverages that can provide health benefits in addition to nutrition. Functional foods, which include products with probiotics, are considered an important source to support the functions of body and prevent disease. Secondly, an increase in health consciousness and awareness among individuals about the importance of gut health is driving this demand. As people are becoming more informed about the role of gut microbiota in overall well-being, they are eager to buy products that benefit their digestive system. Probiotics are a natural product that rebalances the microbiota to improve the gut, thus gaining popularity among health-conscious consumers.

Expansion of Drug Development

Growing research to elucidate the modes of action and therapeutic potential of probiotics is leading to the growing need for conducting high-quality clinical trials to prove their efficacy. Developing a new drug entail running randomized controlled trials that demonstrate the safety and efficacy of clinically validated probiotic strains in treating specific health conditions. These clinical studies generate scientific evidence that supports the use of probiotics as therapeutic agents, thereby boosting consumer confidence and driving probiotics market growth. Moreover, key players are investing in drug development for probiotics while focusing on obtaining patent protection for novel probiotic strains, formulations, and therapeutic applications. In addition, governing agencies are emphasizing the safety and stability of formulation. They are also investing in the manufacturing of drug development and antibiotics across the globe. For example, the Department of Health and Human Services invested $ 40 million in 2022 to expand the role of biomanufacturing for active pharmaceutical ingredients (APIs) and antibiotics.

Thriving Animal Feed Industry

The IMARC Group's report shows that the global animal feed market is expected to reach US$ 674.7 Billion by 2032. Increasingly, people are becoming aware about the viability of animal gut health, not just in livestock and poultry but also in pets. As in humans, the microbiota of the gut is essential in influencing animal health by impacting digestion, nutrient uptake, immune response, and general well-being among other roles. Consequently, animal producers and pet owners are increasingly adopting the use of probiotics in animal food for gut health and overall improvement of animal performance. Probiotics are likewise associated with the reduction of gastrointestinal disorders attributable to enhanced feed efficiency and utilization of nutrients, in addition to the sustainable nature of the development approach. Also, probiotics can be utilized to enhance the productivity and sustainability of animal production ecology.

PROBIOTICS MARKET SEGMENTATION:

Breakup by Ingredient:

  • Bacteria
  • Yeast

Bacteria accounts for the majority of the market share

Bacteria have been widely researched and studied for their health benefits in relation to gut health. Bacteria like Lactobacillus and Bifidobacterium species are known for their ability to promote a healthy balance of microbiota, which is essential for digestion, nutrient absorption, and immune function. In addition, bacteria are easy to incorporate into various products like dairy products, dietary supplements, and functional foods. The well-established research is supporting the health benefits of bacterial probiotics, which is boosting the growth of the segment

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Pharmacies/Drugstores
  • Specialty Stores
  • Online Stores
  • Others

Supermarkets and hypermarkets hold the largest share of the industry

Supermarkets and hypermarkets offer a broad variety of probiotic products from different brands, providing people with ample choices to suit their preferences and needs. The convenience of these stores attracts a large number of people seeking probiotics supplements and food and beverage products. Additionally, they leverage promotional strategies like discounts, special offers, and product placements to expand sales and encourage repeat purchases. Their established distribution networks also allow efficient supply chain management, ensuring consistent availability of probiotics products across the globe.

Breakup by Application:

  • Food and Beverages
  • Dietary Supplements
  • Animal Feed

Food and beverages represent the leading market segment

The incorporation of probiotics into food and beverage products offer a convenient way for consumers to take these beneficial microorganisms into their daily diet, along with the rise in hectic working schedules of people that is encouraging the adoption of ready-to-eat (RTE) meals in which probiotics are included, such as yogurt cups, snack bars, cereal, and beverages, making it easy for people to access the health benefits of probiotics without the need for additional supplementation.

Breakup by Form:

  • Dry
  • Liquid

Liquid exhibits a clear dominance in the market

The liquid probiotics offer a convenient and easy-to-consume formats for probiotics, making them accessible to a broad range of consumers. These probiotics are available in various forms like drinks, shots, and concentrates, allowing people to incorporate them into their daily routines. Moreover, these probiotics have faster absorption rate compared to other forms. They also allow greater flexibility in formulations, enabling key players to create products with diverse probiotic stains and functional ingredients to target specific health issues.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Asia Pacific leads the market, accounting for the largest probiotics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for probiotics.

The growing awareness among the masses about the benefits of probiotics is strengthening the growth of the market across the region. Moreover, rising disposable income of people in countries like China, Japan, and South Korea are driving the demand for probiotic supplements and functional foods to improve digestive health and overall wellness. In addition, governing agencies are undertaking initiatives to promote the use of probiotics in food and beverage products, which is further bolstering the market growth in the region. Besides this, the growing understanding of the importance of preventive health with several studies showing the benefits of these products on immunity, cognitive health, and skincare, along with rising aging population, is catalyzing the probiotics demand. The State Council report of the People's Report of China 2021 shows that the total population of Chinese people on the mainland aged 60 or above has reached 264.02 million, including 190.64 million people aged 65 or above.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major probiotics companies have also been provided. Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd. ()
  • Key players are investing in research and development (R&D) activities to identify new probiotics strains, enhance formulations technologies, and better understand the mechanisms of action and health benefits of probiotics. They are also working with research institutes and healthcare organizations to develop the probiotics products. Moreover, companies are prioritizing quality assurance and control measures to ensure stability and safety of their probiotics products. Key manufacturers are also expanding their product lines to include a broad variety of probiotic formulations targeting different consumers. For instance, in 2021, Lifeway Foods, Inc., the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announced its new line of dairy-free probiotic oat beverage at natural products expo east.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global probiotics market in 2025?

2. What is the expected growth rate of the global probiotics market during 2026-2034?

3. What are the key factors driving the global probiotics market?

4. What has been the impact of COVID-19 on the global probiotics market?

5. What is the breakup of the global probiotics market based on the ingredient?

6. What is the breakup of the global probiotics market based on the distribution channel?

7. What is the breakup of the global probiotics market based on application?

8. What is the breakup of the global probiotics market based on the form?

9. What are the key regions in the global probiotics market?

10. Who are the key players/companies in the global probiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Probiotics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Ingredient

  • 6.1 Bacteria
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Yeast
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Supermarkets and Hypermarkets
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmacies/Drugstores
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Specialty Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Stores
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Food and Beverages
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Dietary Supplements
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Animal Feed
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Form

  • 9.1 Dry
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Liquid
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biogaia AB
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Chr. Hansen Holding A/S
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Danone S.A.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 General Mills Inc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 i-Health Inc (Koninklijke DSM N.V.)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Kerry Group plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lallemand Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Lifeway Foods Inc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Morinaga Milk Industry Co. Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Nestle S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 PepsiCo Inc
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Probi (Symrise AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Yakult Honsha Co.Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제